We are live on ! Find out more
LCP

Legacy Capital Partners Portfolio holdings

AUM $304M
1-Year Est. Return 20.42%
This Fund
S&P 500
This Quarter Est. Return
-6.02%
1 Year Est. Return
+20.42%
3 Year Est. Return
+85.6%
5 Year Est. Return
+136.75%
10 Year Est. Return
–
AUM
$147M
AUM Growth
-$6.21M
Cap. Flow
+$5.43M
Cap. Flow %
3.68%
Top 10 Hldgs %
27.93%
Holding
124
New
11
Increased
49
Reduced
28
Closed
14

Top Buys

Rank Stock Value
1
PCRX icon
Pacira BioSciences
PCRX
+$1.26M
2
ABBV icon
AbbVie
ABBV
+$804K
3
DIS icon
Walt Disney
DIS
+$713K
4
VRSN icon
VeriSign
VRSN
+$554K
5
MAR icon
Marriott International
MAR
+$512K

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$952K
2
EWS icon
iShares MSCI Singapore ETF
EWS
+$929K
3
POT
Potash Corp Of Saskatchewan
POT
+$775K
4
BIDU icon
Baidu
BIDU
+$703K
5
VEU icon
Vanguard FTSE All-World ex-US ETF
VEU
+$477K

Sector Composition

Rank Sector Weight
1 Consumer Staples 18.83%
2 Healthcare 18.08%
3 Technology 16.35%
4 Industrials 11.08%
5 Financials 9.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DD
51
DELISTED
Du Pont De Nemours E I
DD
$942K 0.64%
19,525
-1,193
-6% -$63.7K
HSY icon
52
Hershey
HSY
$35.2B
$938K 0.64%
10,200
-100
-1% -$9.11K
KMB icon
53
Kimberly-Clark
KMB
$36.3B
$923K 0.63%
8,456
+600
+8% +$66.1K
LYB icon
54
LyondellBasell Industries
LYB
$20B
$916K 0.62%
10,985
+350
+3% +$31.1K
DIS icon
55
Walt Disney
DIS
$167B
$911K 0.62%
8,912
+6,545
+277% +$713K
UTHR icon
56
United Therapeutics
UTHR
$25.8B
$893K 0.61%
6,800
– –
TGT icon
57
Target
TGT
$65.6B
$870K 0.59%
11,055
+3,200
+41% +$255K
PCRX icon
58
Pacira BioSciences
PCRX
$1.04B
$849K 0.58%
+20,650
New +$1.26M
BIV icon
59
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
$844K 0.57%
9,940
+57
+0.6% +$4.8K
DE icon
60
Deere & Co
DE
$160B
$760K 0.52%
10,270
-1,000
-9% -$88K
BX icon
61
Blackstone
BX
$102B
$754K 0.51%
24,237
-204
-0.8% -$7.38K
BIIB icon
62
Biogen
BIIB
$30B
$680K 0.46%
2,330
+50
+2% +$16.5K
MRGE
63
DELISTED
MERGE HEALTHCARE INC COM STK (WI)
MRGE
$677K 0.46%
95,300
– –
BSV icon
64
Vanguard Short-Term Bond ETF
BSV
$44.7B
$633K 0.43%
7,865
+60
+0.8% +$4.81K
USB icon
65
US Bancorp
USB
$98.2B
$633K 0.43%
15,417
+400
+3% +$17.3K
GDX icon
66
VanEck Gold Miners ETF
GDX
$22.7B
$619K 0.42%
45,010
-7,200
-14% -$104K
HON icon
67
Honeywell
HON
$77B
$612K 0.42%
7,189
+1,558
+28% +$142K
KLAC icon
68
KLA
KLAC
$239B
$602K 0.41%
120,400
+6,500
+6% +$33.4K
VRSN icon
69
VeriSign
VRSN
$26.2B
$574K 0.39%
+8,125
New +$554K
PRAA icon
70
PRA Group
PRAA
$663M
$571K 0.39%
10,775
– –
ITC
71
DELISTED
ITC HOLDINGS CORP
ITC
$551K 0.37%
16,525
+100
+0.6% +$3.33K
BMY icon
72
Bristol-Myers Squibb
BMY
$133B
$548K 0.37%
9,250
-1,000
-10% -$63.4K
WBA
73
DELISTED
Walgreens Boots Alliance
WBA
$532K 0.36%
6,400
+1,200
+23% +$108K
FL
74
DELISTED
Foot Locker
FL
$513K 0.35%
+7,125
New +$507K
OXY icon
75
Occidental Petroleum
OXY
$56.8B
$504K 0.34%
7,617
-3,074
-29% -$215K
1 2
3
4 5

Similar funds

ANRIA
American National Registered Investment Advisor Galveston, Texas $279M AUM 18.92% 1-Year Est. Return
WA
Winfield Associates Cleveland, Ohio $276M AUM 15.18% 1-Year Est. Return
BHTS
Bar Harbor Trust Services Ellsworth, Maine $331M AUM 19.79% 1-Year Est. Return
SCM
Southport Capital Management Chattanooga, Tennessee $274M AUM 28.84% 1-Year Est. Return
PCA
Permit Capital Advisors West Conshohocken, Pennsylvania $260M AUM
DHGWA
Dixon Hughes Goodman Wealth Advisors Asheville, North Carolina $349M AUM
HWM
Holloway Wealth Management Gainesville, Florida $350M AUM 10.13% 1-Year Est. Return
FPOC
Financial Planners of Cleveland Mayfield Heights, Ohio $238M AUM

Legacy Capital Partners's Q3 2015 Portfolio in Review

As of Q3 2015, Legacy Capital Partners held 124 positions worth $147M, down 4% from $154M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Legacy Capital Partners deployed $5.43M of net new capital in Q3 2015, opening 11 new positions and adding to 49 existing holdings. Its largest new stake was Pacira BioSciences: 20,650 shares worth $849K.

By sector, the portfolio is most concentrated in Consumer Staples at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Potash Corp Of Saskatchewan, an estimated $775K trimmed.

  • Legacy Capital Partners's largest Q3 2015 buy was Pacira BioSciences: 20,650 shares worth $849K.
  • Legacy Capital Partners added most to AbbVie in Q3 2015, an estimated $804K increase.
  • Legacy Capital Partners's biggest Q3 2015 reduction was Potash Corp Of Saskatchewan, cutting an estimated $775K.
  • Legacy Capital Partners fully exited Oracle in Q3 2015, selling an estimated $952K.
  • Legacy Capital Partners's ten largest holdings make up 28% of its $147M portfolio in Q3 2015.
  • Legacy Capital Partners opened 11 new positions and closed 14 in Q3 2015.
  • Legacy Capital Partners's portfolio value fell 4% quarter-over-quarter to $147M.

Based on Legacy Capital Partners's 13F filing for Q3 2015, filed 9 Nov 2015.